Antibodies against the RNase H domain of human hepatitis B virus P protein(s) are frequent markers of acute and chronic virus infection (T. Weimer, K. Weimer, Z.-X. Tu, M.-C. Jung, G. R. Pape, and H. Will, J. Immunol. 143:3750-3756, 1989). In the present study, these antibodies were determined in serial serum samples of experimentally infected chimpanzees and naturally infected human patients with acute and chronic hepatitis B virus infection. Anti-P antibodies were found in the sera of both chimpanzees and humans early in infection shortly after the immunoglobulin M anti-HBc response; they persisted in chronic carriers with ongoing viral replication but declined and disappeared at the time of virus clearance from the sera. These data demonstrate that antibodies to the RNase H domain of the hepatitis B virus P protein are early markers of infection and a signal of ongoing virus replication. Falling titers indicate the decline or end of active virus production and may therefore be a prognostic sign of virus elimination in natural infection and after antiviral therapy.
CITATION STYLE
Weimer, T., Schödel, F., Jung, M. C., Pape, G. R., Alberti, A., Fattovich, G., … Will, H. (1990). Antibodies to the RNase H domain of hepatitis B virus P protein are associated with ongoing viral replication. Journal of Virology, 64(11), 5665–5668. https://doi.org/10.1128/jvi.64.11.5665-5668.1990
Mendeley helps you to discover research relevant for your work.